Ledger.Open graph →

SEC Form D · filed January 21, 2020

Kitov Pharma Ltd

Offering

—

Sold

—

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

TEL AVIV, L3

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Michael Schickler · Tel Aviv, L3Exec Hadas Reuveni · Tel Aviv, L3Exec Ran Tzror · Tel Aviv, L3Director Gil Ben-Menachem · Tel Aviv, L3Exec Ido Agmon · Tel Aviv, L3Director Eric Rowinsky · Tel Aviv, L3Director Isaac Israel · Tel Aviv, L3Exec · Director Simcha Rock · Tel Aviv, L3Director Steven Steinberg · Tel Aviv, L3Director Gil Efron · Tel Aviv, L3Exec Revital Stern-Raff · Tel Aviv, L3Director Stavros Koutsantonis · Exeter, NHExec Aiden S. Redmond · New York, NYExec Jay Bush · BOSTON, MADirector Sanjai N. Bhonsle · Denver, COExec Carl S. Pappo · New York, NYDirector Curtis L. Scribner · Berkeley, CAExec Mark Mcgarry · BOSTON, MADirector Kyle York · BOSTON, MAExec · Director Richard F. Lunsford · conshohocken, PADirector Paul Young · Exeter, NHDirector ArrowMark CLO Equity Strategic Partners Fund GP, LLC · Denver, CODirector Jeffrey Grimberg · Seattle, WADirector Steven J. Grover · Missoula, MTExec Wendy W. Dicicco · Pittsburgh, PADirector Quinn Rotchford · Seattle, WADirector John K. Mastrototaro · Dania Beach, FLDirector Steven K. Seger · Dania Beach, FLExec · Director Scott Baker · Overland, KSDirector Scott Duba · Overland, KSExec Paul R. Gatzmeier · Golden, COExec Robert Aren · Deerfield, ILDirector Vicki Esralew · Deerfield, ILExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗